ISU Abxis Co., Ltd.
ISU Abxis Co., Ltd., a prominent player in the biotechnology sector, is headquartered in South Korea (KR) and operates extensively across Asia and beyond. Founded in 2004, the company has established itself as a leader in the development of innovative diagnostic solutions and therapeutic antibodies, catering to the growing demands of the healthcare industry. ISU Abxis is renowned for its cutting-edge products, including monoclonal antibodies and diagnostic kits, which are distinguished by their high specificity and reliability. The company’s commitment to research and development has led to significant advancements in immunology and molecular diagnostics, positioning it as a trusted partner in the global market. With a focus on quality and innovation, ISU Abxis continues to achieve notable milestones, solidifying its reputation as a key contributor to the biotechnology landscape.
DitchCarbon Score
How does ISU Abxis Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ISU Abxis Co., Ltd.'s score of 15 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
ISU Abxis Co., Ltd.'s reported carbon emissions
ISU Abxis Co., Ltd., headquartered in South Korea (KR), currently does not have available carbon emissions data for recent years, as no specific figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. Additionally, the company has not outlined any formal reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. In the absence of specific emissions data or reduction initiatives, it is essential to note that many companies in the biotechnology sector are increasingly focusing on sustainability and climate action. This trend often includes setting ambitious targets for reducing greenhouse gas emissions and enhancing overall environmental performance. As ISU Abxis Co., Ltd. continues to operate in this evolving landscape, it may consider establishing clear climate commitments to align with industry standards and stakeholder expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ISU Abxis Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
